{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:12:51Z","timestamp":1794406371346,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0210040"],"award-info":[{"award-number":["JP18fk0210040"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0210040"],"award-info":[{"award-number":["JP18fk0210040"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02789"],"award-info":[{"award-number":["18H02789"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005927","name":"Daiichi Sankyo Foundation of Life Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007533","name":"Kobayashi Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007533","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol-Myers Squibb Research Grant, SGH Foundation, MSD Life Science Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic disturbance of lipids is a hallmark of nonalcoholic fatty liver disease (NAFLD). In this study, we measured the serum levels of 15 acylcarnitine species of various carbon chain lengths from 2 to 18 in 241 patients with biopsy-proven NAFLD, including 23 patients with hepatocellular carcinoma (HCC), and analyzed the relationship between serum acylcarnitine profile and NAFLD status. Long-chain acylcarnitines AC14:1 and AC18:1 increased gradually with the progression of fibrosis and further increased in patients with HCC, whereas the middle-chain acylcarnitine AC5:0 exhibited the opposite trend. In particular, AC18:1, which we previously showed to possess a tumor promoting effect, was significantly elevated in patients with HCC compared to those without HCC. In addition, long-chain acylcarntines including AC18:1 were positively correlated with serum levels of inflammatory cytokines. Although none of the acylcarnitine species were independently associated with the presence of HCC, (AC16:0\u2009+\u2009AC18:1)\/AC2:0, an index for the diagnosis of carnitine palmitoyltransferase 2 (CPT2) deficiency, was independently associated with the presence of HCC after adjusting for age and liver fibrosis stage, likely reflecting the downregulation of CPT2 in HCC tissues. Thus, serum acylcarnitine profiles changed significantly according to the status of NAFLD, which may be implicated in the pathogenesis of NAFLD.<\/jats:p>","DOI":"10.1038\/s41598-019-47216-2","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T06:03:15Z","timestamp":1563861795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Kenichiro","family":"Enooku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4109-3421","authenticated-orcid":false,"given":"Naoto","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9430-1426","authenticated-orcid":false,"given":"Yujin","family":"Hoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3021-2517","authenticated-orcid":false,"given":"Ryosuke","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"key":"47216_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, Md.) 64, 73\u201384, https:\/\/doi.org\/10.1002\/hep.28431 (2016).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"47216_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","volume":"69","author":"C Lebeaupin","year":"2018","unstructured":"Lebeaupin, C. et al. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 69, 927\u2013947, https:\/\/doi.org\/10.1016\/j.jhep.2018.06.008 (2018).","journal-title":"J Hepatol"},{"key":"47216_CR3","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.4254\/wjh.v7.i17.2110","volume":"7","author":"H Nakagawa","year":"2015","unstructured":"Nakagawa, H. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis. World J Hepatol 7, 2110\u20132118, https:\/\/doi.org\/10.4254\/wjh.v7.i17.2110 (2015).","journal-title":"World J Hepatol"},{"key":"47216_CR4","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","volume":"113","author":"M Noureddin","year":"2018","unstructured":"Noureddin, M. et al. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances. The American journal of gastroenterology 113, 1649\u20131659, https:\/\/doi.org\/10.1038\/s41395-018-0088-6 (2018).","journal-title":"The American journal of gastroenterology"},{"key":"47216_CR5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/jci23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. The Journal of clinical investigation 115, 1343\u20131351, https:\/\/doi.org\/10.1172\/jci23621 (2005).","journal-title":"The Journal of clinical investigation"},{"key":"47216_CR6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nature medicine 24, 908\u2013922, https:\/\/doi.org\/10.1038\/s41591-018-0104-9 (2018).","journal-title":"Nature medicine"},{"key":"47216_CR7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1053\/jhep.2003.50398","volume":"38","author":"M Perez-Carreras","year":"2003","unstructured":"Perez-Carreras, M. et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 38, 999\u20131007, https:\/\/doi.org\/10.1053\/jhep.2003.50398 (2003).","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"47216_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","volume":"26","author":"Hayato Nakagawa","year":"2014","unstructured":"Nakagawa, H. et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell 26, 331\u2013343, 10.1016\/j.ccr.2014.07.001 (2014).","journal-title":"Cancer Cell"},{"key":"47216_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","volume":"68","author":"F Marra","year":"2018","unstructured":"Marra, F. & Svegliati-Baroni, G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol 68, 280\u2013295, https:\/\/doi.org\/10.1016\/j.jhep.2017.11.014 (2018).","journal-title":"J Hepatol"},{"key":"47216_CR10","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","volume":"67","author":"N Fujiwara","year":"2018","unstructured":"Fujiwara, N. et al. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut 67, 1493\u20131504, https:\/\/doi.org\/10.1136\/gutjnl-2017-315193 (2018).","journal-title":"Gut"},{"key":"47216_CR11","doi-asserted-by":"publisher","first-page":"E1378","DOI":"10.1152\/ajpendo.00656.2013","volume":"306","author":"JM Rutkowsky","year":"2014","unstructured":"Rutkowsky, J. M. et al. Acylcarnitines activate proinflammatory signaling pathways. American journal of physiology. Endocrinology and metabolism 306, E1378\u20131387, https:\/\/doi.org\/10.1152\/ajpendo.00656.2013 (2014).","journal-title":"American journal of physiology. Endocrinology and metabolism"},{"key":"47216_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1096\/fj.14-255901","volume":"29","author":"C Aguer","year":"2015","unstructured":"Aguer, C. et al. Acylcarnitines: potential implications for skeletal muscle insulin resistance. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 29, 336\u2013345, https:\/\/doi.org\/10.1096\/fj.14-255901 (2015).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"47216_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrendo.2015.129","volume":"11","author":"CS McCoin","year":"2015","unstructured":"McCoin, C. S., Knotts, T. A. & Adams, S. H. Acylcarnitines\u2013old actors auditioning for new roles in metabolic physiology. Nat Rev Endocrinol 11, 617\u2013625, https:\/\/doi.org\/10.1038\/nrendo.2015.129 (2015).","journal-title":"Nat Rev Endocrinol"},{"key":"47216_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1053\/j.jrn.2006.01.004","volume":"16","author":"D Fouque","year":"2006","unstructured":"Fouque, D. et al. Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease. Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation 16, 125\u2013131, https:\/\/doi.org\/10.1053\/j.jrn.2006.01.004 (2006).","journal-title":"Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation"},{"key":"47216_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/jren.2003.50010","volume":"13","author":"M Matera","year":"2003","unstructured":"Matera, M. et al. History of L-carnitine: implications for renal disease. Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation 13, 2\u201314 (2003).","journal-title":"Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation"},{"key":"47216_CR16","doi-asserted-by":"publisher","first-page":"e38812","DOI":"10.1371\/journal.pone.0038812","volume":"7","author":"BP Sampey","year":"2012","unstructured":"Sampey, B. P. et al. Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PloS one 7, e38812, https:\/\/doi.org\/10.1371\/journal.pone.0038812 (2012).","journal-title":"PloS one"},{"key":"47216_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3945\/jn.108.103754","volume":"139","author":"SH Adams","year":"2009","unstructured":"Adams, S. H. et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. The Journal of nutrition 139, 1073\u20131081, https:\/\/doi.org\/10.3945\/jn.108.103754 (2009).","journal-title":"The Journal of nutrition"},{"key":"47216_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1015109127986","volume":"25","author":"K Gempel","year":"2002","unstructured":"Gempel, K. et al. Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry. Journal of inherited metabolic disease 25, 17\u201327 (2002).","journal-title":"Journal of inherited metabolic disease"},{"key":"47216_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00216-012-5782-4","volume":"403","author":"L Zhou","year":"2012","unstructured":"Zhou, L. et al. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases. Analytical and bioanalytical chemistry 403, 203\u2013213, https:\/\/doi.org\/10.1007\/s00216-012-5782-4 (2012).","journal-title":"Analytical and bioanalytical chemistry"},{"key":"47216_CR20","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1194\/jlr.M085613","volume":"59","author":"KY Peng","year":"2018","unstructured":"Peng, K. Y. et al. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. Journal of lipid research 59, 1977\u20131986, https:\/\/doi.org\/10.1194\/jlr.M085613 (2018).","journal-title":"Journal of lipid research"},{"key":"47216_CR21","doi-asserted-by":"publisher","first-page":"e0193138","DOI":"10.1371\/journal.pone.0193138","volume":"13","author":"ME Romero-Ibarguengoitia","year":"2018","unstructured":"Romero-Ibarguengoitia, M. E. et al. Family history and obesity in youth, their effect on acylcarnitine\/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach. PloS one 13, e0193138, https:\/\/doi.org\/10.1371\/journal.pone.0193138 (2018).","journal-title":"PloS one"},{"issue":"5","key":"47216_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/mc.22967","volume":"58","author":"Xin Lu","year":"2019","unstructured":"Lu, X. et al. Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2. Molecular carcinogenesis, https:\/\/doi.org\/10.1002\/mc.22967 (2019).","journal-title":"Molecular Carcinogenesis"},{"key":"47216_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.humpath.2011.07.005","volume":"43","author":"M Salomao","year":"2012","unstructured":"Salomao, M. et al. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. Hum Pathol 43, 737\u2013746, https:\/\/doi.org\/10.1016\/j.humpath.2011.07.005 (2012).","journal-title":"Hum Pathol"},{"key":"47216_CR24","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/his.12343","volume":"64","author":"J Shibahara","year":"2014","unstructured":"Shibahara, J., Ando, S., Sakamoto, Y., Kokudo, N. & Fukayama, M. Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients. Histopathology 64, 951\u2013962, https:\/\/doi.org\/10.1111\/his.12343 (2014).","journal-title":"Histopathology"},{"key":"47216_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315448","author":"N Senni","year":"2018","unstructured":"Senni, N. et al. beta-catenin-activated hepatocellular carcinomas are addicted to fatty acids. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2017-315448 (2018).","journal-title":"Gut"},{"key":"47216_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00428-015-1836-2","volume":"467","author":"S Ando","year":"2015","unstructured":"Ando, S., Shibahara, J., Hayashi, A. & Fukayama, M. beta-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study. Virchows Archiv: an international journal of pathology 467, 535\u2013542, https:\/\/doi.org\/10.1007\/s00428-015-1836-2 (2015).","journal-title":"Virchows Archiv: an international journal of pathology"},{"issue":"11","key":"47216_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/cancers10110447","volume":"10","author":"Hayato Nakagawa","year":"2018","unstructured":"Nakagawa, H. et al. Lipid Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers 10, https:\/\/doi.org\/10.3390\/cancers10110447 (2018).","journal-title":"Cancers"},{"key":"47216_CR28","doi-asserted-by":"publisher","first-page":"e7929","DOI":"10.1371\/journal.pone.0007929","volume":"4","author":"E Mas","year":"2009","unstructured":"Mas, E. et al. IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis. PloS one 4, e7929, https:\/\/doi.org\/10.1371\/journal.pone.0007929 (2009).","journal-title":"PloS one"},{"key":"47216_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197\u2013208, https:\/\/doi.org\/10.1016\/j.cell.2009.12.052 (2010).","journal-title":"Cell"},{"key":"47216_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","volume":"155","author":"G He","year":"2013","unstructured":"He, G. et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155, 384\u2013396, https:\/\/doi.org\/10.1016\/j.cell.2013.09.031 (2013).","journal-title":"Cell"},{"key":"47216_CR31","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.3748\/wjg.v18.i31.4071","volume":"18","author":"H Nakagawa","year":"2012","unstructured":"Nakagawa, H. & Maeda, S. Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World J Gastroenterol 18, 4071\u20134081, https:\/\/doi.org\/10.3748\/wjg.v18.i31.4071 (2012).","journal-title":"World J Gastroenterol"},{"key":"47216_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ekir.2016.12.003","volume":"2","author":"JJ Liu","year":"2017","unstructured":"Liu, J. J. et al. Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease. Kidney international reports 2, 470\u2013480, https:\/\/doi.org\/10.1016\/j.ekir.2016.12.003 (2017).","journal-title":"Kidney international reports"},{"key":"47216_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","volume":"63","author":"N Fujiwara","year":"2015","unstructured":"Fujiwara, N. et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63, 131\u2013140, https:\/\/doi.org\/10.1016\/j.jhep.2015.02.031 (2015).","journal-title":"J Hepatol"},{"key":"47216_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1320.003","volume":"1033","author":"CJ Rebouche","year":"2004","unstructured":"Rebouche, C. J. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Annals of the New York Academy of Sciences 1033, 30\u201341, https:\/\/doi.org\/10.1196\/annals.1320.003 (2004).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"47216_CR35","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1542\/peds.108.1.e19","volume":"108","author":"JC Wood","year":"2001","unstructured":"Wood, J. C. et al. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant\u2019s newborn screening card. Pediatrics 108, E19, https:\/\/doi.org\/10.1542\/peds.108.1.e19 (2001).","journal-title":"Pediatrics"},{"key":"47216_CR36","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. American journal of kidney diseases: the official journal of the National Kidney Foundation 53, 982\u2013992, https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.034 (2009).","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"47216_CR37","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 41, 1313\u20131321, https:\/\/doi.org\/10.1002\/hep.20701 (2005).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"47216_CR38","doi-asserted-by":"publisher","first-page":"e15543","DOI":"10.1371\/journal.pone.0015543","volume":"5","author":"Y Hoshida","year":"2010","unstructured":"Hoshida, Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PloS one 5, e15543, https:\/\/doi.org\/10.1371\/journal.pone.0015543 (2010).","journal-title":"PloS one"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47216-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47216-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47216-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:51:37Z","timestamp":1671259897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47216-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47216"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47216-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]},"assertion":[{"value":"7 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10663"}}